Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI108812

Circulating Immune Complexes after Renal Transplantation: CORRELATION OF INCREASED 125I-C1q BINDING ACTIVITY WITH ACUTE REJECTION CHARACTERIZED BY FIBRIN DEPOSITION IN THE KIDNEY

Yuet M. Ooi, Boon S. Ooi, Enrique H. Vallota, Martin R. First, and Victor E. Pollak

Division of Nephrology, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Division of Pediatric Nephrology, Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Find articles by Ooi, Y. in: PubMed | Google Scholar

Division of Nephrology, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Division of Pediatric Nephrology, Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Find articles by Ooi, B. in: PubMed | Google Scholar

Division of Nephrology, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Division of Pediatric Nephrology, Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Find articles by Vallota, E. in: PubMed | Google Scholar

Division of Nephrology, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Division of Pediatric Nephrology, Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Find articles by First, M. in: PubMed | Google Scholar

Division of Nephrology, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Division of Pediatric Nephrology, Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Department of Pediatrics, University of Cincinnati Medical Center, Cincinnati, Ohio 45267

Find articles by Pollak, V. in: PubMed | Google Scholar

Published September 1, 1977 - More info

Published in Volume 60, Issue 3 on September 1, 1977
J Clin Invest. 1977;60(3):611–619. https://doi.org/10.1172/JCI108812.
© 1977 The American Society for Clinical Investigation
Published September 1, 1977 - Version history
View PDF
Abstract

To assess the role of circulating immune complexes in the pathogenesis of acute rejection, sera were measured for such complexes by the 125I-C1q binding assay in 45 normal subjects, 24 allografted patients undergoing acute rejection, and in 11 allografted patients in a quiescent phase. Increased C1q-binding activity (C1q-BA) was detected in 14 patients with acute rejection, 9 of whom had renal biopsies showing fibrin deposition in the vasculature together with cellular infiltrates in the tubulo-interstitial structures; renal histology was not available in the other 5 patients. The other 10 patients with acute rejection, whose biopsies showed only cellular infiltrates, and the 11 patients in a quiescent phase posttransplantation did not have increased levels of serum C1q-BA.

Of the group with increased serum C1q-BA, serial studies in eight patients showed a correlation between increased serum C1q-BA and the occurrence of rejection; with reversal by therapy, serum C1q-BA returned to within normal levels. Complexes from six patients were analyzed by sucrose density gradient ultracentrifugation to have sedimentation coefficients ranging from 15S to 18.4S. After acid dissociation and analysis by double-diffusion techniques, C1q-reactive complexes were shown to contain IgG. Immunofluorescent studies done in five renal biopsies from this group revealed granular deposits of immunoglobulin, and (or) less frequently, of complement in the glomeruli or the tubular basement membranes.

The findings suggest that circulating immune complexes may mediate the type of acute rejection characterized by fibrin deposition in the kidney. The role of circulating immune complexes arising from the recipient's original kidney disease could be excluded in 10 patients with humoral rejection, inasmuch as the underlying renal pathology was of a “nonimmunologic” nature; this was corroborated by sequential studies in six patients in whom circulating immune complexes could not be demonstrated before rejection. The participation of administered antilymphocyte globulin (ALG) as an antigen also appears to be excluded in four patients, two who were not given ALG, and in two of whom episodes of rejection occurred unrelated temporally to ALG administration.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 611
page 611
icon of scanned page 612
page 612
icon of scanned page 613
page 613
icon of scanned page 614
page 614
icon of scanned page 615
page 615
icon of scanned page 616
page 616
icon of scanned page 617
page 617
icon of scanned page 618
page 618
icon of scanned page 619
page 619
Version history
  • Version 1 (September 1, 1977): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts